DrugPatentWatch Database Preview
Akorn Inc Company Profile
» See Plans and Pricing
US Patents for Akorn Inc
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Akorn Inc | HYDASE | hyaluronidase | INJECTABLE;INJECTION | 021716 | 001 | 2005-10-25 | RE47849 | HOUGH EAR INSTITUTE (Oklahoma City, OK) | 2022-12-18 | DISCN | search | |
| Akorn Inc | HYDASE | hyaluronidase | INJECTABLE;INJECTION | 021716 | 001 | 2005-10-25 | RE37336 | The Board of Regents of the University of Oklahoma (Norman, OK) | 2040-03-31 | DISCN | search | |
| Akorn Inc | HYDASE | hyaluronidase | INJECTABLE;INJECTION | 021716 | 001 | 2005-10-25 | 9,994,849 | SAMSUNG ELECTRONICS CO., LTD. (Suwon-si, KR) | 2035-12-24 | DISCN | search | |
| Akorn Inc | HYDASE | hyaluronidase | INJECTABLE;INJECTION | 021716 | 001 | 2005-10-25 | 9,993,529 | Halozyme, Inc. (San Diego, CA) | 2028-04-28 | DISCN | search | |
| Akorn Inc | HYDASE | hyaluronidase | INJECTABLE;INJECTION | 021716 | 001 | 2005-10-25 | 9,981,021 | KINETIQ, INC. (Claremont, CA) | 2035-04-09 | DISCN | search | |
| Akorn Inc | HYDASE | hyaluronidase | INJECTABLE;INJECTION | 021716 | 001 | 2005-10-25 | 9,968,676 | Genentech, Inc. (South San Francisco, CA) | 2029-07-31 | DISCN | search | |
| Akorn Inc | HYDASE | hyaluronidase | INJECTABLE;INJECTION | 021716 | 001 | 2005-10-25 | 9,931,382 | Osio Corporation (Coronado, CA) | 2023-12-19 | DISCN | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
